Business Description
Check Point Software Technologies Ltd. develops, markets, and supports a range of products and services for IT security worldwide. The company offers a portfolio of network security, endpoint security, data security, and management solutions. It provides Check Point Infinity Architecture, a cyber security architecture that protects against 5th and 6th generation cyber-attacks across various networks, endpoint, cloud, workloads, Internet of Things, and mobile. The company also offers security gateways and software platforms that support small and medium sized business (SMB) to large enterprise data center and telco-grade environments; and threat prevention technologies and zero-day protections. In addition, the company provides cloud network security, security and posture management, cloud workload protection, and cloud web application protection for web applications and APIs; and Check Point Harmony that delivers endpoint and secure connectivity for remote user access. Further, the company provides technical customer support programs and plans; professional services in implementing, upgrading, and optimizing Check Point products comprising design planning and security implementation; and certification and educational training services on Check Point products. It sells its products through multiple distribution channels, including distributors, resellers, system integrators, original equipment manufacturers, and managed security service providers. Check Point Software Technologies Ltd. was incorporated in 1993 and is headquartered in Tel Aviv, Israel.
Business History
Generated: Jun 5, 2026 1:00pmPrice Overview
Last updated: Jun 2, 2026 3:05pm (24d ago)Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 9.85
Total Equity: $2.88B
Shares: 109,900,000
Total Debt: $1.97B
Cash: $1.80B
EBITDA: $924.00M
Total Debt: $1.97B
Cash: $1.80B
Revenue: $2.73B
Revenue: $2.73B
Revenue: $2.73B
Total Equity: $2.88B
Tax Rate: -11.8%
Equity: $2.88B
Total Debt: $1.97B
Cash: $1.80B
Current Liabilities: $1.94B
Long-Term Debt: $1.97B
Total Debt: $1.97B
Total Equity: $2.88B
Shares: 109,900,000
Shares: 109,900,000
CapEx: -$26.60M
Shares: 109,900,000
Stock Price: $139.05
Net Income: $1.06B
Industry Benchmarks
Advanced Analysis Forensic deep-dive · three lenses
Check Point is a textbook mature, self-funding software business: $2.73B revenue in 2025 with 86.7% gross margin, $1.06B net income, and $1.21B FCF. The balance sheet carries $3.01B in liquid cash and $1.04B net cash (21% of market cap), Altman Z of 5.44 sits firmly in the safe zone, and earnings quality is clean (OCF/NI 1.3x, accruals -4.2% of assets, Beneish -2.7). Per-share value is being concentrated, not eroded — diluted share count fell from 134.1M (2021) to 109.9M (2025), a -4.9% CAGR, with buybacks running 875% of SBC despite SBC at a fairly normal 7.5% of revenue.
The blemish is the operating margin slide: 41.9% → 38.0% → 37.2% → 34.2% → 30.5% over five years, a ~1140 bps drop, while revenue only grew at a modest ~5.9% CAGR. Gross margin held (~87-88%), so the leakage is in opex — likely R&D and S&M reinvestment to defend against faster-growing peers (Palo Alto, CRWD, ZS). Net income still rose to $1.06B in 2025 (helped by buyback math and possibly non-operating items, since op margin fell), but the underlying operating leverage is going the wrong way.
Insider activity is neutral/benign — one small Chelouche option-exercise-and-sell and routine awards/gifts, no meaningful open-market buying or panic selling. This is a high-integrity, durable franchise that's no longer a growth story; the question for quality is whether margin compression stabilizes or continues.
Verify before trusting this (5)
- Source of 2025 net income jump despite lower op margin — interest income on cash, tax benefit, or one-time item?
- Segment/product mix: is legacy gateway/firewall revenue masking weakness in Harmony/CloudGuard, or are newer products actually growing?
- Customer concentration and renewal/retention rates from the 10-K — is the moat still intact?
- R&D and S&M dollar growth vs revenue — is margin compression a deliberate reinvestment cycle or structural cost creep?
- Whether buyback pace can be sustained at current FCF, and any recent change in capital-allocation policy under new CEO Nadav Zafrir
The e2e composite fair value of $218 (signal-adj $243) leans heavily on a DCF of $292 that assumes Check Point's mid-single-digit growth and compressing 30% op margins reverse course. That's the heroic case and I'm discounting it. The more defensible anchors are the EPV floor at $113 (basically today's price for a no-growth scenario) and the anchored-PE at $176. Splitting those gives a deserved value roughly in the $150-175 range for a high-quality but decelerating cash compounder.
Against $136, that's a ~15-25% gap — real but not screaming. The market is pricing CHKP as a melting ice cube that still throws off cash, and given the 42%→30% margin slide on 6% growth, that's not crazy. Earnings quality is high (score 3), buybacks are real, balance sheet is fortress — so I'm not haircutting the numbers further. The mispricing is modest: you're paid to wait via buybacks and cash, but you're not buying a dollar for fifty cents.
Verify before trusting this (5)
- Operating margin trajectory in next 2 quarters — is the 42%→30% slide stabilizing or continuing?
- Infinity/subscription mix as % of revenue and its growth rate vs legacy product
- Buyback pace and share count reduction vs prior year
- Any guidance on R&D/S&M spend normalization that would restore margin
- Net new customer logos and net retention vs CRWD/PANW disclosures
The macro tape is roughly neutral and CHKP's 0.49 beta means the broader VIX 17 backdrop barely registers here - this is a name driven by its own story, not the index. That story is the problem. The active narrative casts Check Point as the slow incumbent in a cohort where CrowdStrike and Palo Alto own the AI-native, platform-consolidation mindshare. Intensity is only moderate and cult is low, but durability is what hurts: this 'legacy firewall' framing has been ossifying for years and analysts are not lifting a finger to challenge it - zero target revisions this month and a Hold consensus with more Sells (5) than Strong Buys (0). The April 30 print made it worse: an earnings beat got steamrolled by a 2026 guide-cut and a billings miss, dropping the stock 14.8% and validating the bear thesis that growth is structurally fading. That is a recent, concrete narrative wound that has not been re-papered. On the other side, the tailwinds are thin and passive: a $152 consensus target sits 22% above spot (mild positive carry), the low beta insulates against any risk-off flare, and cybersecurity as a sector is not out of favor - peers are working, which actually deepens the relative-performance sting rather than helping CHKP. Net: a quiet, grinding headwind, not a crash risk.
Verify before trusting this (4)
- Next earnings print - any reacceleration in billings or Infinity/cloud disclosure that cracks the legacy-vendor frame
- Whether any analyst breaks from the Hold pack with an upgrade or raised target post-Q2
- Relative tape vs PANW/CRWD - if peers stumble, CHKP's narrative penalty can compress quickly
- M&A or buyback acceleration that would reframe the cash-cow story as shareholder-friendly rather than stagnant
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
Last updated: Jun 1, 2026 4:35pm (25d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $2.2B | $2.3B | $2.4B | $2.6B | $2.7B |
| Cost of Revenue | $258.1M | $304.4M | $282.6M | $319.3M | $361.8M |
| Gross Profit | $1.9B | $2.0B | $2.1B | $2.2B | $2.4B |
| Operating Expenses | $1.0B | $1.1B | $1.2B | $1.4B | $1.5B |
| Operating Income | $907.5M | $884.3M | $899.1M | $876.0M | $831.1M |
| Net Income | $815.6M | $796.9M | $840.3M | $845.7M | $1.1B |
| EBITDA | $938.2M | $920.5M | $1.0B | $1.1B | $924.0M |
| EPS | $6.13 | $6.36 | $7.19 | $7.65 | $9.85 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
Last updated: Jun 2, 2026 3:05pm (24d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $271.9M | $196.0M | $537.7M | $506.2M | $1.8B |
| Total Current Assets | $2.3B | $2.3B | $2.3B | $2.2B | $4.0B |
| Total Assets | $5.9B | $5.7B | $5.7B | $5.8B | $7.8B |
| Current Liabilities | $1.7B | $1.8B | $1.9B | $1.9B | $1.9B |
| Long-Term Debt | $0 | $0 | $0 | $0 | $2.0B |
| Total Liabilities | $2.6B | $2.8B | $2.9B | $3.0B | $4.9B |
| Total Equity | $3.3B | $2.9B | $2.8B | $2.8B | $2.9B |
| Retained Earnings | $11.5B | $12.3B | $13.2B | $14.0B | $15.1B |
Cash Flow (Annual)
Last updated: Jun 1, 2026 4:35pm (25d ago)| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.2B | $1.1B | $1.0B | $1.1B | $1.2B |
| Capital Expenditure | -$15.9M | -$22.1M | -$18.6M | -$24.2M | -$26.6M |
| Free Cash Flow | $1.2B | $1.1B | $1.0B | $1.0B | $1.2B |
| Acquisitions (net) | -$219.7M | -$48.3M | -$458.8M | -$185.8M | -$273.1M |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | -$1.3B | -$1.3B | -$1.3B | -$1.3B | -$1.4B |
| Net Change in Cash | $16.2M | -$75.9M | $341.7M | -$31.5M | $1.3B |
Analyst Estimates (Annual)
Last updated: Jun 2, 2026 3:05pm (24d ago)| Metric | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Revenue |
$2.7B $2.7B – $2.7B
|
$2.8B $2.8B – $2.9B
|
$3.0B $2.9B – $3.1B
|
$3.1B $3.1B – $3.2B
|
| EBITDA |
$1.1B $1.1B – $1.1B
|
$1.1B $1.1B – $1.2B
|
$1.2B $1.2B – $1.2B
|
$1.3B $1.3B – $1.3B
|
| Net Income |
$1.2B $1.2B – $1.2B
|
$1.1B $1.1B – $1.2B
|
$1.3B $1.2B – $1.3B
|
$1.4B $1.3B – $1.6B
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
Last updated: Jun 1, 2026 4:35pm (25d ago)| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +7.5% | +3.6% | +6.2% | +6.3% |
| Gross Profit Growth | +6.1% | +5.3% | +5.3% | +5.3% |
| Operating Income Growth | -2.6% | +1.7% | -2.6% | -5.1% |
| Net Income Growth | -2.3% | +5.4% | +0.6% | +25.0% |
| EBITDA Growth | -1.9% | +11.1% | +3.2% | -12.5% |
Insider Trading (Recent)
Last updated: Jun 2, 2026 3:10pm (24d ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-11 | Shavit Shenhav Tal | S-Sale | 25,000.00 | $123.07 | $3.1M |
| 2026-06-11 | Shavit Shenhav Tal | M-Exempt | 25,000.00 | $114.23 | $2.9M |
| 2026-06-11 | UNGERMAN JERRY T | S-Sale | 25,000.00 | $122.55 | $3.1M |
| 2026-06-11 | UNGERMAN JERRY T | M-Exempt | 25,000.00 | $114.23 | $2.9M |
| 2026-06-02 | Chelouche Yoav | S-Sale | 25,000.00 | $140.28 | $3.5M |
| 2026-06-02 | Chelouche Yoav | M-Exempt | 25,000.00 | $114.23 | $2.9M |
| 2026-05-26 | SHWED GIL | G-Gift | 3,000.00 | $0.00 | $0 |
| 2026-05-10 | Golan Roei | A-Award | 658.00 | $0.00 | $0 |
| 2026-05-10 | Kremer Nataly | A-Award | 658.00 | $0.00 | $0 |
| 2026-05-01 | Seddik Sherif | 0.00 | $0.00 | $0 | |
| 2026-05-01 | Seddik Sherif | 41,935.00 | $190.77 | $8.0M | |
| 2026-03-18 | Rothrock Ray A. | 0.00 | $0.00 | $0 | |
| 2026-03-18 | Rothrock Ray A. | 15,000.00 | $122.41 | $1.8M | |
| 2026-03-18 | Rothrock Ray A. | 15,000.00 | $123.05 | $1.8M | |
| 2026-03-18 | Rothrock Ray A. | 15,000.00 | $122.12 | $1.8M | |
| 2026-03-18 | Rothrock Ray A. | 5,000.00 | $131.96 | $659,800 | |
| 2026-03-18 | Rothrock Ray A. | 5,000.00 | $173.21 | $866,050 | |
| 2026-03-18 | Rothrock Ray A. | 5,000.00 | $191.47 | $957,350 | |
| 2026-03-18 | UNGERMAN JERRY T | 0.00 | $0.00 | $0 | |
| 2026-03-18 | UNGERMAN JERRY T | 25,000.00 | $114.23 | $2.9M |
Narrative Economics
market-narrative step).
Delvantic AI Findings
Looking at the raw numbers first: revenue went from $2.17B (2021) to $2.73B (2025) — a 5.9% CAGR that decelerated in the middle and reaccelerated to 6.3% YoY most recently. Operating income actually declined from $907M (2021) to $831M (2025), meaning the entire net income growth from $816M to $1.06B came from below-the-line items (likely interest income on the $1.8B cash pile and tax). That's important: operating leverage is negative over five years despite 26% cumulative revenue growth. Gross margin at 87% is intact, but operating margin compressed from ~42% to ~30%. This is not a "fortress compounding" story — it's a company spending more (likely on Infinity/cloud R&D and sales) to defend a 6% growth rate.
The quarterly cadence is also noisier than the synthesis admits. Q3 2025 net income of $358.7M on $677.5M revenue (52.9% margin) is an obvious tax/one-time benefit — Q3 2024 margin was 32.6%. Strip that and TTM earnings quality looks weaker; the 25% recent earnings YoY is partially manufactured by that single quarter. The Q1 2026 print of $668.4M revenue / 28.7% margin is fine but not accelerating. So when synthesis says "fair value $243 vs $136" off a DCF, I'd ask what FCF growth rate it assumed — at 6% revenue growth with eroding operating margins, a 13x P/E and ~12x EV/FCF is roughly where mature, low-growth software with no dividend trades. The synthesis model and market-forces model flatly contradict each other (undervalued +79% vs "likely value trap"); I lean toward market-forces being directionally correct on the operating story but the synthesis being correct that the stock is cheap on absolute cash flow.
The contrarian read both ways: the bear case (Palo Alto, CrowdStrike, Zscaler eating the next-gen perimeter) is real and is visible in the operating margin compression — Check Point is paying more to stand still. But CHKP carries no debt, $1.8B cash (~13% of market cap), generates $1.2B FCF on $14.2B EV (~8.5% FCF yield), and trades at 13.5x earnings in a sector where peers trade 40-80x. Insider activity is mildly negative (net selling, plus gifts), not a screaming red flag but no insider is stepping up either. The narrative layer's "quiet quality" framing is fair but understates that this is also a company with zero dividend and no buyback discipline visible in the file — where is the $1.2B FCF going? Without that detail, the cash-cow thesis has a hole.
I dissent from synthesis's $243 fair value — that requires either margin recovery or growth re-acceleration, and the five-year operating income trend says neither is happening. I also dissent from market-forces' "value trap" framing — an 8.5% FCF yield with net cash and 6% organic growth is not a trap, it's a low-multiple cash compounder being mispriced as terminal. Fair value sits in the $165-185 range: roughly 15-17x earnings or a 7% FCF yield, reflecting durable but slow growth, no dividend, and real competitive pressure. That's ~25-35% upside, not 79%. The catalyst question matters: without buyback acceleration, a dividend initiation, or Infinity actually showing accelerating ARR, this drifts. With any of those, it re-rates to $180+. Position sizing should reflect that this is a slow re-rate, not a sharp snap-back.
GPT Critique
In my independent review of Check Point Software Technologies, the raw data presents a company that showcases both strengths and challenges. Revenue growth from $2.17 billion in 2021 to $2.73 billion in 2025 corresponds to a 5.9% CAGR, slightly below the industry average for high-growth tech sectors, but steady. The company maintains an impressive gross margin of 87%, indicating robust pricing power and cost control. However, the decline in operating income from $907 million in 2021 to $831 million in 2025, alongside a reduction in operating margins from approximately 42% to 30%, points to increased spending potentially aimed at innovation and market competitiveness. This suggests a strategy focused on sustaining growth in a rapidly evolving cybersecurity landscape, possibly through investment in the Infinity Architecture and cloud capabilities. The net income growth to $1.06 billion seems driven by non-operational factors, as operating leverage remains negative, raising questions about the sustainability of net income improvements without operational efficiency gains.
I find myself in agreement with several of Opus's assessments. He rightly notes the operating margin compression, which is indeed significant and aligns with the strategic expenditures likely aimed at countering competitive pressures from next-gen cybersecurity firms like Palo Alto and CrowdStrike. I also concur with Opus's skepticism regarding the valuation synthesis's assertion of a $243 fair value. Such a projection appears optimistic given the current growth trajectory and margin dynamics. Opus's fair value estimate of $165-185 aligns more closely with a conservative outlook that factors in Check Point's strong cash flow and balance sheet but also acknowledges the competitive challenges and need for operational improvement.
However, I diverge from Opus in a few areas. He mentions the "value trap" narrative yet suggests a notable potential upside of 25-35%. While I agree that the 8.5% FCF yield is attractive, the narrative of being a "low-multiple cash compounder" might underestimate the severity of the competitive pressures and the impact of continued margin erosion. Additionally, while Opus highlights the lack of dividend or buyback discipline, which I also see as a potential issue, I am more concerned about the absence of clear strategic allocation of their substantial cash reserves toward value-creating opportunities.
A careful skeptic might argue that both Opus and I are underestimating the potential for Check Point to execute a successful turnaround or strategic pivot. They might point to the company's strong cash position as a war chest for acquisitions or strategic partnerships that could catalyze growth and margin recovery. Furthermore, skeptics could argue that the market is overly penalizing Check Point for perceived staleness without sufficient consideration of potential product enhancements or market expansions.